Class I
Drug Recall: libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box, UPC 7 05105 83073 5.
Pyramids Wholesale Inc. · March 19, 2024
Reason for Recall
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Distribution
Nationwide in the USA
States Affected
NATIONWIDE
Quantity Affected
7 boxes
Source: FDA (openFDA Drug Enforcement)
Recall number: D-0454-2024
Status: ongoing
SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.